Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC
Collins, Shauna M., Bakan, Courtney E., Swartzel, Gina D., Hofmeister, Craig C., Efebera, Yvonne A., Kwon, Hakju, Starling, Gary C., Ciarlariello, David, Bhaskar, Shakthi, Briercheck, Edward L., Hughes, Tiffany, Yu, Jianhua, Rice, Audie, Benson, Don M.
Published in Cancer Immunology, Immunotherapy (01.12.2013)
Published in Cancer Immunology, Immunotherapy (01.12.2013)
Get full text
Journal Article
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
Benson, Don M., Bakan, Courtney E., Zhang, Shuhong, Collins, Shauna M., Liang, Jing, Srivastava, Shivani, Hofmeister, Craig C., Efebera, Yvonne, Andre, Pascale, Romagne, Francois, Bléry, Mathieu, Bonnafous, Cécile, Zhang, Jianying, Clever, David, Caligiuri, Michael A., Farag, Sherif S.
Published in Blood (08.12.2011)
Published in Blood (08.12.2011)
Get full text
Journal Article
IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody for Multiple Myeloma: Interm Phase 1 Trial Results and Correlative Biologic and Safety Data
Benson, Don M, Bakan, Courtney E, Padmanaban, Swaminathan, Abonour, Rafat, Suvannasankha, Attaya, Jagannath, Sundar, Chari, Ajai, Clever, David, Kalu, Chidimma, Collins, Shauna, Alghothani, Yousef, Hofmeister, Craig C., Efebera, Yvonne, Blanchet, Stephane, Caligiuri, Michael A., Farag, Sherif
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article